Cognitive function is largely intact in methadone maintenance treatment patients

References

• Applebaum AJ, Bullis JR, Traeger LN, O’Cleirigh C, Otto MW, Pollack MH, Safren SA. 2010. Rates of mood and anxiety disorders and contributors to continued heroin use in methadone maintenance patients: a comparison by HIV status. Neurobehav HIV Med. 2010:49–57.
   PubMedGoogle Scholar
• Baldacchino A, Balfour DJ, Passetti F, Humphris G, Matthews K. 2012. Neuropsychological consequences of chronic opioid use: a quantitative review and meta-analysis. Neurosci Biobehav Rev. 36:2056–2068.
   PubMed Web of Science ®Google Scholar
• Barahmand U, Tavakolian E, Khazaee A, Mohammadi K. 2016. Hot and cold executive functions in pure opioid users undergoing methadone maintenance treatment: effects of methadone dose, treatment duration, and time between last methadone administration and testing. Nigerian J Clin Pract. 19:603–610.
   PubMed Web of Science ®Google Scholar
• Bart G. 2012. Maintenance medication for opiate addiction: the foundation of recovery. J Addict Dis. 31:207–225.
   PubMed Web of Science ®Google Scholar
• Bracken BK, Trksak GH, Penetar DM, Tartarini WL, Maywalt MA, Dorsey CM, Lukas SE. 2012. Response inhibition and psychomotor speed during methadone maintenance: impact of treatment duration, dose, and sleep deprivation. Drug Alcohol Depend. 125:132–139.
   PubMed Web of Science ®Google Scholar
• Clair J, Martin L, Bond AJ, O'Ryan D, Davis P, Curran HV. 2009. An experimental study of aggressive and neutral interpretative bias in opiate-dependent and opiate-abstinent men. J Psychopharmacol. 23:428–435.
   PubMed Web of Science ®Google Scholar
• Darke S, Sims J, McDonald S, Wickes W. 2000. Cognitive impairment among methadone maintenance patients. Addiction. 95:687–695.
   PubMed Web of Science ®Google Scholar
• Davis PE, Liddiard H, Mcmillan TM. 2002. Neuropsychological deficits and opiate abuse. Drug Alcohol Depend. 67:105–108.
   PubMed Web of Science ®Google Scholar
• De Maeyer J, Vanderplasschen W, Lammertyn J, van Nieuwenhuizen C, Broekaert E. 2011. Exploratory study on domain-specific determinants of opiate-dependent individuals' quality of life. Eur Addict Res. 17:198–210.
   PubMed Web of Science ®Google Scholar
• Doniger GM. 2014. NeuroTrax guide to normative data. Available from: https://portal.neurotrax.com/docs/norms_guide.pdf
   Google Scholar
• Dwolatzky T, Whitehead V, Doniger GM, Simon ES, Schweiger A, Jaffe D, Chertkow H. 2003. Validity of a novel computerized cognitive battery for mild cognitive impairment. BMC Geriatr. 3:4.
   PubMedGoogle Scholar
• Fareed A, Casarella J, Amar R, Vayalapalli S, Drexler K. 2009. Benefits of retention in methadone maintenance and chronic medical conditions as risk factors for premature death among older heroin addicts. J Psychiatr Pract. 15:227–234.
   PubMed Web of Science ®Google Scholar
• Hawks RL. 1986. Analytical methodology. NIDA Res Monogr. 73:30–42.
   PubMedGoogle Scholar
• James B, Wayne H, Karen B. 2006. Changes in criminal activity after entering methadone maintenance. Br J Addict. 87:251–258.
   Google Scholar
• Kavé G. 2005. Phonemic fluency, semantic fluency, and difference scores: normative data for adult Hebrew speakers. J Clin Exp Neuropsychol. 27:690–699.
   PubMed Web of Science ®Google Scholar
• Kavé G, Knafo-Noam A. 2015. Lifespan development of phonemic and semantic fluency: Universal increase, differential decrease. J Clin Exp Neuropsychol. 37:751–763.
   PubMed Web of Science ®Google Scholar
• Kimura D. 1999. Sex differences in the brain. Sci Am. 10:26–31.
   Google Scholar
• Lezak MD, Howieson DB, Bigler ED, Tranel D. 2012. Neuropsychological assessment. 5th ed. New York: Oxford University Press; p. 693–696.
   Google Scholar
• Liao DL, Huang CY, Hu S, Fang SC, Wu CS, Chen WT, Lee TS, Chen PC, Li CS. 2014. Cognitive control in opioid dependence and methadone maintenance treatment. PLoS One. 9:e94589.
   PubMed Web of Science ®Google Scholar
• Lin WC, Chou KH, Chen HL, Huang CC, Lu CH, Li SH, Wang YL, Cheng YF, Lin CP, Chen CC. 2012. Structural deficits in the emotion circuit and cerebellum are associated with depression, anxiety and cognitive dysfunction in methadone maintenance patients: a voxel-based morphometric study. Psychiatry Res. 201:89–97.
   PubMed Web of Science ®Google Scholar
• Mattick RP, Breen C, Kimber J, Davoli M. 2014. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database Syst Rev. 2:CD002207.
   PubMed Web of Science ®Google Scholar
• Mazhari S, Keshvari Z, Sabahi A, Mottaghian S. 2015. Assessment of cognitive functions in methadone maintenance patients. Addict Health. 7:109–116.
   PubMedGoogle Scholar
• McLellan AT, Luborsky L, O'Brien CP, Barr HL, Evans F. 1984. The addiction severity index in three different populations. NIDA Res Monogr. 55:217–223.
   PubMedGoogle Scholar
• Mintzer MZ, Stitzer ML. 2002. Cognitive impairment in methadone maintenance patients. Drug Alcohol Depend. 67:41–51.
   PubMed Web of Science ®Google Scholar
• Neurotrax Corporation. 2014. Mindstreams Cognitive Health Assessment [Computer Software].Modiin, lsrael.
   Google Scholar
• Peles E, Adelson M. 2006. Gender differences and pregnant women in a methadone maintenance treatment (MMT) clinic. J Addict Dis. 25:39–45.
   PubMed Web of Science ®Google Scholar
• Peles E, Schreiber S, Adelson M. 2014. Deleterious effects of benzodiazepine abuse among methadone maintenance treatment patients. Heroin Addict Rel Clin Probl. 16:63–70.
   Web of Science ®Google Scholar
• Peles E, Schreiber S, Domany Y, Sason A, Tene O, Adelson M. 2014. Achievement of take-home dose privileges is associated with better-perceived sleep and with cognitive status among methadone maintenance treatment patients. W J Biol Psychiatry. 15:620–628.
   PubMed Web of Science ®Google Scholar
• Peles E, Schreiber S, Sason A, Adelson M. 2011. Earning ‘take-home’ privileges and long-term outcome in a methadone maintenance treatment program. J Addict Med. 5:92–98.
   PubMed Web of Science ®Google Scholar
• Pirastu R, Fais R, Messina M, Bini V, Spiga S, Falconieri D, Diana M. 2006. Impaired decision-making in opiate-dependent subjects: effect of pharmacological therapies. Drug Alcohol Depend. 83:163–168.
   PubMed Web of Science ®Google Scholar
• Prosser J, Cohen LJ, Steinfeld M, Eisenberg D, London ED, Galynker II. 2006. Neuropsychological functioning in opiate-dependent subjects receiving and following methadone maintenance treatment. Drug Alcohol Depend. 84:240–247.
   PubMed Web of Science ®Google Scholar
• Prosser J, London ED, Galynker II. 2009. Sustained attention in patients receiving and abstinent following methadone maintenance treatment for opiate dependence: performance and neuroimaging results. Drug Alcohol Depend. 104:228–240.
   PubMed Web of Science ®Google Scholar
• Rapeli P, Fabritius C, Kalska H, Alho H. 2011. Cognitive functioning in opioid-dependent patients treated with buprenorphine, methadone, and other psychoactive medications: stability and correlates. BMC Clin Pharmacol. 21:11–13.
   Google Scholar
• Rass O, Kleykamp BA, Vandrey RG, Bigelow GE, Leoutsakos JM, Stitzer ML, Strain EC, Copersino ML, Mintzer MZ. 2014. Cognitive performance in methadone maintenance patients: effects of time relative to dosing and maintenance dose level. Exp Clin Psychopharmacol. 22:248–256.
   PubMed Web of Science ®Google Scholar
• Sartor CE, Kranzler HR, Gelernter J. 2014. Rate of progression from first use to dependence on cocaine or opioids: a cross-substance examination of associated demographic, psychiatric, and childhood risk factors. Addict Behav. 39:473–479.
   PubMed Web of Science ®Google Scholar
• Shidlansik L, Adelson M, Peles E. 2016. Knowledge and stigma regarding methadone maintenance treatment (MMT) among personnel of MMT and non MMT addiction facilities in Israel. J Addict Dis. 2017. 36:30–37.
   PubMed Web of Science ®Google Scholar
• Specka M, Finkbeiner T, Lodemann E, Leifert K, Kluwig J, Gastpar M. 2000. Cognitive-motor performance of methadone-maintained patients. Eur Addict Res. 6:8–19.
   PubMed Web of Science ®Google Scholar
• Strain EC, Harrison JA, Bigelow GE. 2011. Induction of opioid-dependent individuals onto buprenorphine and buprenorphine/naloxone soluble-films. Clin Pharmacol Ther. 89:443–449.
   PubMed Web of Science ®Google Scholar
• Troyer AK, Moscovitch M, Winocur G. 1997. Clustering and switching as two components of verbal fluency: Evidence from younger and older healthy adults. Neuropsychology. 11:138–146.
   PubMed Web of Science ®Google Scholar
• Van Holst RJ, Schilt T. 2011. Drug-related decrease in neuropsychological functions of abstinent drug users. Curr Drug Abuse Rev. 4:42–56.
   PubMedGoogle Scholar
• Vigna-Taglianti FD, Burroni P, Mathis F, Versino E, Beccaria F, Rotelli M, Garneri M, Picciolini A, Bargagli AM. VEdeTTE Study Group. 2016. Gender differences in heroin addiction and treatment: results from the VEdeTTE cohort. Subst Use Misuse. 51:295–309.
   PubMed Web of Science ®Google Scholar
• Wang GY, Wouldes TA, Kydd R, Jensen M, Russell BR. 2014. Neuropsychological performance of methadone-maintained opiate users. J Psychopharmacol (Oxford). 28:789–799.
   PubMed Web of Science ®Google Scholar
• Wang GY, Wouldes TA, Russell BR. 2013. Methadone maintenance treatment and cognitive function: a systematic review. Curr Drug Abuse Rev. 6:220–230.
   PubMedGoogle Scholar
• Zilles D, Lewandowski M, Vieker H, Henseler I, Diekhof E, Melcher T, Keil M, Gruber O. 2016. Gender differences in verbal and visuospatial working memory performance and networks. Neuropsychobiology. 73:52–63.
   PubMed Web of Science ®Google Scholar